220 related articles for article (PubMed ID: 11751422)
1. Mechanisms of tolerance to DNA damaging therapeutic drugs.
Karran P
Carcinogenesis; 2001 Dec; 22(12):1931-7. PubMed ID: 11751422
[TBL] [Abstract][Full Text] [Related]
2. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
[TBL] [Abstract][Full Text] [Related]
3. Mismatch repair and response to DNA-damaging antitumour therapies.
Bignami M; Casorelli I; Karran P
Eur J Cancer; 2003 Oct; 39(15):2142-9. PubMed ID: 14522371
[TBL] [Abstract][Full Text] [Related]
4. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
Moreland NJ; Illand M; Kim YT; Paul J; Brown R
Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
[TBL] [Abstract][Full Text] [Related]
5. Mismatch repair defects as a cause of resistance to cytotoxic drugs.
Irving JA; Hall AG
Expert Rev Anticancer Ther; 2001 Jun; 1(1):149-58. PubMed ID: 12113123
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of human DNA repair: an update.
Christmann M; Tomicic MT; Roos WP; Kaina B
Toxicology; 2003 Nov; 193(1-2):3-34. PubMed ID: 14599765
[TBL] [Abstract][Full Text] [Related]
7. Mismatch repair, G(2)/M cell cycle arrest and lethality after DNA damage.
Aquilina G; Crescenzi M; Bignami M
Carcinogenesis; 1999 Dec; 20(12):2317-26. PubMed ID: 10590226
[TBL] [Abstract][Full Text] [Related]
8. Human mismatch repair, drug-induced DNA damage, and secondary cancer.
Karran P; Offman J; Bignami M
Biochimie; 2003 Nov; 85(11):1149-60. PubMed ID: 14726020
[TBL] [Abstract][Full Text] [Related]
9. Altering DNA base excision repair: use of nuclear and mitochondrial-targeted N-methylpurine DNA glycosylase to sensitize astroglia to chemotherapeutic agents.
Harrison JF; Rinne ML; Kelley MR; Druzhyna NM; Wilson GL; Ledoux SP
Glia; 2007 Nov; 55(14):1416-25. PubMed ID: 17674369
[TBL] [Abstract][Full Text] [Related]
10. DNA mismatch repair, microsatellite instability and cancer.
Vaish M; Mittal B
Indian J Exp Biol; 2002 Sep; 40(9):989-94. PubMed ID: 12587725
[TBL] [Abstract][Full Text] [Related]
11. New drugs, new drug resistance mechanisms.
Hall AG; Irving J
Expert Rev Anticancer Ther; 2002 Jun; 2(3):239-40. PubMed ID: 12113037
[No Abstract] [Full Text] [Related]
12. Combined mismatch and nucleotide excision repair defects in a human cell line: mismatch repair processes methylation but not UV- or ionizing radiation-induced DNA damage.
O'Driscoll M; Martinelli S; Ciotta C; Karran P
Carcinogenesis; 1999 May; 20(5):799-804. PubMed ID: 10334196
[TBL] [Abstract][Full Text] [Related]
13. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
Liu L; Markowitz S; Gerson SL
Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the DNA mismatch repair system in antineoplastic drug resistance.
Lage H; Dietel M
J Cancer Res Clin Oncol; 1999; 125(3-4):156-65. PubMed ID: 10235469
[TBL] [Abstract][Full Text] [Related]
15. DNA repair pathways and cisplatin resistance: an intimate relationship.
Rocha CRR; Silva MM; Quinet A; Cabral-Neto JB; Menck CFM
Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e478s. PubMed ID: 30208165
[TBL] [Abstract][Full Text] [Related]
16. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
Aebi S; Fink D; Gordon R; Kim HK; Zheng H; Fink JL; Howell SB
Clin Cancer Res; 1997 Oct; 3(10):1763-7. PubMed ID: 9815561
[TBL] [Abstract][Full Text] [Related]
17. Selection for genome instability by DNA damage in human cells: unstable microsatellites and their consequences for tumourigenesis.
Hampson R
Radiat Oncol Investig; 1997; 5(3):111-4. PubMed ID: 9303066
[TBL] [Abstract][Full Text] [Related]
18. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).
Fedier A; Fink D
Int J Oncol; 2004 Apr; 24(4):1039-47. PubMed ID: 15010846
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability in human cancer: a prognostic marker for chemotherapy?
Claij N; te Riele H
Exp Cell Res; 1999 Jan; 246(1):1-10. PubMed ID: 9882509
[TBL] [Abstract][Full Text] [Related]
20. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.
Vaisman A; Varchenko M; Umar A; Kunkel TA; Risinger JI; Barrett JC; Hamilton TC; Chaney SG
Cancer Res; 1998 Aug; 58(16):3579-85. PubMed ID: 9721864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
